ImmuMap enter into service agreement with CytoVac
ImmuMap Services ApS enter into service agreement with CytoVac A/S under which ImmuMap Services will perform immune monitoring of samples from CytoVac’s innovative ALECSAT therapy for undisclosed cancer targets.